Back to search
FDAFDA · Food and drugs·Recall number D-1568-2014

Atropine Sulfate 0.4 mg/ml Injection, USP, Total Dosage 0.8 mg per 2 mL, 3 mL pre-filled syringe, Rx Only. Pharmakon Pharmaceuticals, Inc., 14450 Getz Road, Noblesville, IN. NDC: 45183-0105-78.

Published September 3, 2014 · Recall initiated: April 21, 2014

Summary

FDA records drug Class I recall D-1568-2014, published September 3, 2014 and initiated April 21, 2014. Recalling firm: Pharmakon Pharmaceuticals; Status: Terminated; Reported quantity: 5 Syringes; Lot: Lot #: E0333282R; Exp: 7/13/2014. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Incorrect/ Undeclared Excipient: Contains undeclared benzyl alcohol.

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Pharmakon Pharmaceuticals
Distributor
United States: TX, IL, MD, IN
Lot
Lot #: E0333282R; Exp: 7/13/2014
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Atropine Sulfate 0.4 mg/ml Injection, USP, Total Dosage 0.8 mg per 2 mL, 3 mL pre-filled syringe, Rx Only. Pharmakon Pharmaceuticals, Inc., 14450 Getz Road, Noblesville, IN. NDC: 45183-0105-78. recalled?

Yes. FDA published recall D-1568-2014 on September 3, 2014. Reported hazard: Incorrect/ Undeclared Excipient: Contains undeclared benzyl alcohol.

What should I do if I have this product?

Voluntary: Firm initiated · Telephone